SCHEMBL7987767

SCHEMBL7987767

CCCCOc1ccc(-c2nc3ncn(Cc4ccccc4)c3c(=O)[nH]2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.50
ALDH1A1 P00352 3/20 0.50
HPGD P15428 2/20 0.50
KMT2A Q03164 1/20 0.49
GUSB P08236 1/20 0.46
CYP1B1 Q16678 1/20 0.44
CSNK2A2 P19784 1/20 0.43
CSNK2B P67870 1/20 0.43
CSNK2A1 P68400 1/20 0.43
GAA P10253 2/20 0.43
BRD4 O60885 1/20 0.43
ADORA2B P29275 3/20 0.42
HTT P42858 2/20 0.42
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ADORA3 P0DMS8 2/20 0.41
PRMT5 O14744 1/20 0.41
ADORA1 P30542 1/20 0.41
ATP4A P20648 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974476 0.92 GUSB (0.56) SMN1; SMN2ALDH1A1HPGDKMT2AGUSB
SCHEMBL7985391 0.90 HPGD (0.47) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7985230 0.89 ALDH1A1 (0.53) SMN1; SMN2ALDH1A1HPGDKMT2AGUSB
SCHEMBL7984451 0.87 ALDH1A1 (0.46) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7975265 0.86 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7985702 0.84 HPGD (0.50) SMN1; SMN2ALDH1A1HPGDKMT2AGUSB
SCHEMBL7975129 0.84 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7984453 0.84 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1HPGDKMT2AGUSB
SCHEMBL7987774 0.84 CNOT7 (0.46) SMN1; SMN2GUSBCYP1B1ADORA2BHTT
SCHEMBL7985069 0.84 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1HPGDKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed